Both 0.5 and 2.5 mg/kg flavopiridol treatment completely reduced CKD-mediated CHOP induction (Fig. 4B), resulting in marked attenuation of CKD-dependent medial calcification in DBA/2J mice (Fig. 4, C–E). The gene discussed is DDIT3; the disease is chronic kidney disease.